Table 2.
Patient-reported outcomes at baseline (n = 40)
| Patient-reported outcome at baseline | Completed (n) | n (%) |
|---|---|---|
| NCCN distress thermometer | 40 | |
| 0–3 (no distress – low distress) | 8 (20.0) | |
| 4–10 (moderate – high distress) | 32 (80.0) | |
| Functional Activity Scale | 40 | |
| 13 Item score (ADLs + IADLS) | ||
| 0–2 | 20 (50.0) | |
| 3–6 | 11 (27.5) | |
| 7–13 | 9 (22.5) | |
| 7 Item score (ADLs) | ||
| 0 | 30 (75.0) | |
| 1 | 7 (17.5) | |
| 2 | 2 (5.0) | |
| ≥ 3 | 1 (2.5) | |
| EORTC--Quality of Life Questionnaire, mean (SD) | 39 | |
| Symptom score (range 0–100) | 36.4 (17.4) | |
| Functional score (range 0–100) | 46.7 (37.6) | |
| Global Health score (range 0–100) | 47.9 (21.2) | |
| EORTC – Lung Cancer Supplement score (range 0–100) | 26.8 (12.3) | |
| Hospital Anxiety and Depression Scale | 39 | |
| Depression score total, mean (SD) | 6.7 (4.4) | |
| Depression score ≥ 8 | 17 (43.6) | |
| Anxiety score total, mean (SD) | 6.9 (4.5) | |
| Anxiety score ≥ 8 | 14 (35.9) |
NCCN, National Comprehensive Cancer Network; EORTC, European Organization for Research and Treatment of Cancer
Notes: One patient did not complete both the EORTC-Quality of Life Questionnaire and the Hospital Anxiety and Depression Scale. A score ≥ 8 on Hospital Anxiety and Depression Scale indicates clinically significant anxiety and/or depression and was found to best correlate with the Montgomery-Asberg Depression Rating Scale (MADRS) [17]